British scientist and Nobel laureate Michael Houghton has joined Hong Kong Baptist University (HKBU) to pursue a vaccine for hepatitis C, a viral infection that affects the liver, aiming to prove it effective by 2030 as part of a bold vision to eliminate the disease as a threat.
